soul trial oral semaglutide cardiovascular outcomes nejm 2024 2025 Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6 Semaglutide and Cardiovascular Outcomes in

What is the difference between the pen and the vial version

The authors also highlighted analysis results from the DunedinPACE third-generation clock: Semaglutide was associated with a 0.09 lower pace of aging (units per year) relative to placebo, translating to an ~9% slower pace of biological aging in the semaglutide group. The same trend was not seen in causality-enriched clocks, which identify epigenetic changes that cause age-related traits and diseases, rather than those that are simply correlated

Weight loss of 13 lbs is typical at this stage

If you become pregnant while taking isotretinoin, its essential to contact your doctor immediately

& Dufour P

Key highlights GLP-1 medications such as Ozempic, Wegovy, and Mounjaro can cost $800-$1,300 per month without insurance coverage, making them unaffordable for many patients